Suppr超能文献

非创伤性急诊患者使用生物补片立即关闭腹腔与开放性腹腔临时关闭的比较(CLOSE-UP研究)

Immediate Closure of Abdominal Cavity with Biologic Mesh versus Temporary Abdominal Closure of Open Abdomen in Non-Trauma Emergency Patients (CLOSE-UP Study).

作者信息

de Vries Fleur E E, Claessen Jeroen J M, Atema Jasper J, van Ruler Oddeke, Boermeester Marja A

机构信息

Department of Surgery, Amsterdam University Medical Center, Amsterdam, the Netherlands.

Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.

出版信息

Surg Infect (Larchmt). 2020 Oct;21(8):694-703. doi: 10.1089/sur.2019.289. Epub 2020 Feb 25.

Abstract

In more than 10% of emergency laparotomies in non-trauma patients, primary fascial closure is not achievable because of excessive visceral edema, which leaves the patient with an open abdomen (OA). An OA harbors an inherent high risk of serious complications, and temporary closure devices are used to achieve delayed fascial closure. A potential new strategy in preventing OA is immediate closure during the emergency procedure with a non-crosslinked biologic mesh. This is a prospective comparative cohort feasibility study in 13 teaching hospitals in the Netherlands. Non-trauma patients who underwent emergency laparotomy in which regular sutured primary fascial closure was not achievable because of excessive intra-abdominal edema were eligible. In one cohort, Biomesh (n = 20), the abdominal cavity was immediately closed at the emergency laparotomy with a non-crosslinked biologic mesh. In a parallel cohort, Control (n = 20), the resulting OA was managed by temporary abdominal closure (TAC; inlay polyglactin [Vicryl™] mesh [n = 7]) or commercial (ABThera) abdominal negative pressure therapy device (n = 13)). The primary end point was the proportion of closed abdominal cavities at 90 days. At 90 days, 65% (13/20) of the abdominal cavities were closed in the Biomesh cohort versus 45% (9/20) in Controls (p = 0.204). In the Biomesh cohort, seven of 20 (35%) patients had at least one major complication versus 15 of 20 (75%) patients in the Control cohort (p = 0.011). Both the median number of intensive care unit (ICU) and mechanical ventilation days were significantly lower in the Biomesh cohort; one versus 10 (p = 0.002) and 0 versus four (p 0.003) days, respectively. The number of abdominal reoperations was significantly lower in the Biomesh cohort (median 0 vs. two, p < 0.001; total number five vs. 44). If primary fascial closure cannot be achieved at the emergency laparotomy in non-trauma patients, immediate abdominal closure by use of a non-crosslinked biologic mesh prevents OA management. This results in a non-significant higher proportion of closed abdominal cavities at 90 days compared with OA management with TAC techniques, and in a significant reduction of major complications and reoperations, and a shorter ICU stay.

摘要

在非创伤患者超过10%的急诊剖腹手术中,由于内脏过度水肿,无法进行一期筋膜缝合,导致患者腹部开放(OA)。OA存在严重并发症的固有高风险,需使用临时闭合装置实现延迟筋膜缝合。一种预防OA的潜在新策略是在急诊手术期间使用非交联生物补片进行即时闭合。这是一项在荷兰13家教学医院开展的前瞻性比较队列可行性研究。纳入因腹腔内水肿严重而无法进行常规缝合一期筋膜缝合的非创伤性急诊剖腹手术患者。在一个队列中(生物补片组,n = 20),在急诊剖腹手术时用非交联生物补片立即闭合腹腔。在平行队列(对照组,n = 20)中,对形成的OA采用临时腹部闭合(TAC;镶嵌聚乙醇酸[薇乔™]补片[n = 7])或商用(ABThera)腹部负压治疗装置(n = 13)进行处理。主要终点是90天时腹腔闭合的比例。90天时,生物补片组65%(13/20)的腹腔闭合,而对照组为45%(9/20)(p = 0.20④)。在生物补片组,20例患者中有7例(35%)至少发生1次严重并发症,而对照组20例患者中有15例(75%)发生(p = 0.011)。生物补片组重症监护病房(ICU)住院天数和机械通气天数的中位数均显著更低,分别为1天对10天(p = 0.002)和0天对4天(p = 0.003)。生物补片组腹部再次手术的次数显著更少(中位数0次对2次,p < 0.001;总数5次对44次)。如果在非创伤患者的急诊剖腹手术中无法实现一期筋膜缝合,使用非交联生物补片立即闭合腹部可避免OA的处理。与采用TAC技术处理OA相比,这使得90天时腹腔闭合的比例虽无显著提高,但严重并发症和再次手术显著减少,且ICU住院时间缩短。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验